Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-30 17:45 |
Amoéba announces its half-year results for 2021 and continues to develop its bi…
|
English | PDF • 311.0 KB | ||
| 2021-09-03 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 222.8 KB | ||
| 2021-08-24 17:45 |
Amoéba : une 2e campagne d’essais sur les céréales confirme le potentiel de son…
|
French | PDF • 292.3 KB | ||
| 2021-08-24 17:45 |
Amoéba : a 2nd cereal trial campaign confirms the potential of its biocontrol p…
|
English | PDF • 259.0 KB | ||
| 2021-07-29 17:45 |
AMOEBA : Résultats prometteurs de l’application Biocontrôle-Vigne dans une très…
|
French | PDF • 291.9 KB | ||
| 2021-07-29 17:45 |
AMOEBA : Promising results of the Biocontrol-Grapevine application despite a ve…
|
English | PDF • 267.5 KB | ||
| 2021-07-06 17:45 |
AMOEBA annonce l’émission de la seconde tranche de 60 obligations convertibles …
|
French | PDF • 346.3 KB | ||
| 2021-07-06 17:45 |
AMOEBA announces the issuance of the second tranche of 60 bonds convertible int…
|
English | PDF • 293.8 KB | ||
| 2021-07-02 17:45 |
AMOEBA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
|
French | PDF • 386.9 KB | ||
| 2021-07-01 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 231.0 KB | ||
| 2021-06-24 18:00 |
AMOEBA : DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISE PAR L’ASSEMBLEE G…
|
French | PDF • 333.8 KB | ||
| 2021-06-24 17:45 |
AMOEBA : Evolution de la composition du Conseil d’Administration d’AMOEBA
|
French | PDF • 250.7 KB | ||
| 2021-06-24 17:45 |
AMOEBA: Evolution of the composition of the Board of Directors of AMOEBA
|
English | PDF • 220.0 KB | ||
| 2021-06-02 18:15 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 230.1 KB | ||
| 2021-06-02 17:45 |
AMOEBA : Modalités de mise à disposition des documents préparatoires / Assembl…
|
French | PDF • 267.0 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
